Henri B. Kagan | |
---|---|
Born | |
Alma mater | Sorbonne, École nationale supérieure de chimie de Paris, Collège de France |
Awards | Wolf Prize in Chemistry (2001) The Ryoji Noyori Prize (2002) |
Scientific career | |
Fields | Asymmetric catalysis |
Institutions | Université Paris-Sud |
Henri Boris Kagan (born 15 December 1930) is currently an emeritus professor at the Université Paris-Sud in France. He is widely recognized as a pioneer in the field of asymmetric catalysis. His discoveries have had far-reaching impacts on the pharmaceutical industry.[1]
He graduated from the Sorbonne and École nationale supérieure de chimie de Paris and carried out his PhD under J. Jacques at the Collège de France. Subsequently, he was a research associate with A. Horeau. He then moved to Université Paris-Sud, Orsay where he is emeritus professor. A landmark in his research was the development of C2-symmetric ligands, e.g., DIOP for asymmetric catalysis.[2] This discovery led to the discovery of many related ligands that support catalysts used in a variety of practical applications.